Janux Therapeutics revenue was $10.59M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JANX annual revenue was $10.6M, with 31% growth year-over-year.
JANX past revenue growth
How has JANX's revenue growth performed historically?
Janux Therapeutics (NASDAQ: JANX) reported Q4 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Janux Therapeutics's revenue was $2.46 million.
What was Janux Therapeutics's revenue in 2024?
Janux Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $10.59 million, a 30.99% increase year over year.
How much does Janux Therapeutics make in a day?
Based on Janux Therapeutics annual revenue for the past five years, JANX makes an average of $16,942.47 per day.
What was Janux Therapeutics's annual revenue growth in the past year?
As of Q2 2025, Janux Therapeutics's revenue has grown 30.99% year over year. This is 466.7 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Janux Therapeutics's revenue in the past year totaled $10.59 million.
How much does Janux Therapeutics make in a year?
Janux Therapeutics's revenue by year for the past five years is:
Janux Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $10.59 million, a 30.99% increase year over year.
Janux Therapeutics's annual revenue for Dec 31, 2023 was $8.08 million, a 6.14% decrease from 2022.
Janux Therapeutics's annual revenue for 2022 was $8.61 million, a 136.79% increase from 2021.
Janux Therapeutics's annual revenue for 2021 was $3.64 million, a Infinity% increase from 2020.
Janux Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.